Patents Assigned to Boehringer Ingelheim Animal Health, Inc.
  • Patent number: 10345292
    Abstract: The following discloses mammalian cells lines that stably express functional nematode acetylcholine receptor subunits. The resulting expression of functional ion channels has been made possible by the stable co-expression of the chaperone protein, RIC3. These cell lines are extremely useful for the high throughput screening (HTS) of compounds, to identify new candidate parasiticidal, including nematocidal, active ingredients.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: July 9, 2019
    Assignees: BOEHRINGER INGELHEIM ANIMAL HEALTH INC., SANOFI
    Inventors: Lance Hammerland, Brenda Bondesen, Jean-Marie Chambard, Thierry Vermat, Werner Dittrich, Michel Partiseti, Qing Zhou-Liu, Cathy Cojean, Rachid Boukaiba, Eric Tagat
  • Publication number: 20030170269
    Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic “mystery swine disease” and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
    Type: Application
    Filed: October 28, 2002
    Publication date: September 11, 2003
    Applicant: Boehringer Ingelheim Animal Health, Inc.
    Inventors: James E. Collins, David A. Benfield, Danny W. Chladek, Louis L. Harris, David E. Gorcyca
  • Publication number: 20010021383
    Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic “mystery swine disease” and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
    Type: Application
    Filed: December 18, 2000
    Publication date: September 13, 2001
    Applicant: Boehringer Ingelheim Animal Health, Inc.
    Inventors: James E. Collins, David A. Benfield, Danny W. Chladek
  • Patent number: 5846805
    Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic "mystery swine disease" and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: December 8, 1998
    Assignees: Boehringer Ingelheim Animal Health, Inc., South Dakota State University, Regents of University of Minnesota
    Inventors: James E. Collins, David A. Benfield, Danny W. Chladek, Louis L. Harris, David E. Gorcyca
  • Patent number: 5840563
    Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic "mystery swine disease" and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
    Type: Grant
    Filed: July 9, 1996
    Date of Patent: November 24, 1998
    Assignee: Boehringer Ingelheim Animal Health, Inc.
    Inventors: Danny W. Chladek, Louis L. Harris, David E. Gorcyca
  • Patent number: 5672507
    Abstract: An improved bio-reactor with spiral or coil-shaped filling bodies is disclosed, the improvement comprising use of a gas diffusion tube through which air, oxygen or other gases can be bubbled through the fermentation medium.
    Type: Grant
    Filed: February 24, 1995
    Date of Patent: September 30, 1997
    Assignee: Boehringer Ingelheim Animal Health, Inc.
    Inventor: Walter Merk
  • Patent number: 5476778
    Abstract: A viral agent that will mimic "mystery swine" disease has been isolated and described, together with a method of growing the viral agent in vitro, and a method of attenuating the virus for vaccine preparation.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: December 19, 1995
    Assignee: Boehringer Ingelheim Animal Health, Inc.
    Inventors: Danny W. Chladek, David E. Gorcyca, Louis L. Harris
  • Patent number: 5075295
    Abstract: Novel aqueous oxytetracycline compositions comprising oxytetracycline, polyethylene glycol with a mean molecular weight of 400, and magnesium oxide. These compositions have good clarity and low viscosity.
    Type: Grant
    Filed: December 12, 1989
    Date of Patent: December 24, 1991
    Assignee: Boehringer Ingelheim Animal Health, Inc.
    Inventors: Jacob A. Zupan, Deborah L. Steinbrenner